Insider Trading Activity Second Sight Medical Products, Inc. – Director Bought 17,020 shares of Stock

ME Staff
-
0

Insider Trading Activity For Second Sight Medical Products, Inc.

Gregg Williams , Director of Second Sight Medical Products, Inc. reportedly Bought 17,020 shares of the company’s stock at an average price of 1.18 for a total transaction amount of $20,083.60 SEC Form

Insider Trading History For Second Sight Medical Products, Inc.

  • On 11/19/2014 Gregg Williams, Director, bought 111,111 with an average share price of $9.00 per share and the total transaction amounting to $999,999.00.View SEC Filing
  • On 3/23/2015 Robert J Greenberg, CEO, sold 100,000 with an average share price of $13.28 per share and the total transaction amounting to $1,328,000.00.View SEC Filing
  • On 5/27/2015 Anne-Marie Juliette Ripley, VP, sold 45,629 with an average share price of $13.04 per share and the total transaction amounting to $595,002.16.View SEC Filing
  • On 6/3/2015 Robert J Greenberg, CEO, sold 150,000 with an average share price of $14.04 per share and the total transaction amounting to $2,106,000.00.View SEC Filing
  • On 6/4/2015 Anne-Marie Juliette Ripley, VP, sold 4,371 with an average share price of $15.00 per share and the total transaction amounting to $65,565.00.View SEC Filing
  • On 12/4/2015 Anne-Marie Juliette Ripley, VP, sold 2,500 with an average share price of $5.50 per share and the total transaction amounting to $13,750.00.View SEC Filing
  • On 12/7/2015 Robert J. Greenberg, Chairman, sold 17,969 with an average share price of $5.30 per share and the total transaction amounting to $95,235.70.View SEC Filing

    • Analyst Ratings For Second Sight Medical Products, Inc.
    These are 0 Sell Ratings, 0 Hold Ratings, 1 Buy Rating, 0 Strong Buy Ratings .
    The current consensus rating for Second Sight Medical Products, Inc. is Buy (Score: 3.00) with a consensus target price of $5.00 , a potential (338.60% upside)

    Analyst Ratings History For Second Sight Medical Products, Inc.

    • On 7/26/2016 Rodman & Renshaw Reiterated Rating Buy with a price target of $16.00
    • On 11/6/2017 HC Wainwright Reiterated Rating Buy with a price target of $5.00

    Recent Trading Activity for Second Sight Medical Products, Inc.
    Shares of Second Sight Medical Products, Inc. closed the previous trading session at with shares trading hands.